# FATE THERAPEUTICS INC (FATE) MD&A by fiscal year

Verbatim Item 7 Management's Discussion and Analysis sections from FATE THERAPEUTICS INC's 10-K filings, one page per fiscal year. Extracted from SEC filings with the same bounded parser for every year. Filer text, not grepcent analysis or investment advice.

- [FY 2025 MD&A](/company/FATE/mda/fy2025/): filed 2026-02-26; accession 0001193125-26-073699 (https://www.sec.gov/Archives/edgar/data/1434316/000119312526073699/fate-20251231.htm); latest 10-K
- [FY 2024 MD&A](/company/FATE/mda/fy2024/): filed 2025-03-05; accession 0000950170-25-033510 (https://www.sec.gov/Archives/edgar/data/1434316/000095017025033510/fate-20241231.htm)
- [FY 2023 MD&A](/company/FATE/mda/fy2023/): filed 2024-02-26; accession 0000950170-24-020158 (https://www.sec.gov/Archives/edgar/data/1434316/000095017024020158/fate-20231231.htm)
- [FY 2022 MD&A](/company/FATE/mda/fy2022/): filed 2023-02-28; accession 0000950170-23-005067 (https://www.sec.gov/Archives/edgar/data/1434316/000095017023005067/fate-20221231.htm)
- [FY 2021 MD&A](/company/FATE/mda/fy2021/): filed 2022-02-28; accession 0000950170-22-002293 (https://www.sec.gov/Archives/edgar/data/1434316/000095017022002293/fate-20211231.htm)

Back to /company/FATE/